SILICON VALLEY, Calif., March 26, 2018 -- Cloud based medical office platform PracticeSuite announced today it has achieved Stage 3 Meaningful Use certification of its electronic health record (EHR) software for general medicine and a number of health specialties through InfoGard, an ONC-authorized certification body (ONC-ACB).
This certification places PracticeSuite among 23 elite healthcare software companies that offer Stage III Meaningful Use certification with Clinical Quality Measures and DirectTrust® project certification, which are key requirements to qualify for Medicare's Merit Based Incentive Payments System (MIPS) under MACRA. The list of ONC Certified EHR products is down from 4000 Stage II products, to fewer than 300 Stage III certified products.
“PracticeSuite is emerging as a true cloud healthcare platform for outpatient care," states its CEO Vinod Nair. "But moving forward, it is imperative that physicians select a one stop solution and eliminate multiple technology vendors in order to stay ahead of cost, compliance, and care requirements."
"PracticeSuite’s Cloud Platform offers the ability to Care, Collect, Connect, Collaborate, build Credibility, prevent Cyberattacks, and remain Compliant,” states Mr. Nair. “PracticeSuite is looking out for the needs of its client beyond the horizon.”
About PracticeSuite, Inc.
PracticeSuite is a Silicon Valley cloud computing platform for outpatient care that provides end-to-end medical office solutions. It serves 155 billing specialties and 61 clinical specialties, and over 41,000 clinical professionals use its system to serve their patients. Platform features include clinical and practice management software, revenue cycle management services, and the required interoperability to comply with Medicare's Merit Based Incentive Payments System (MIPS) under MACRA––Medicare's Access and CHIP Reauthorization Act of 2015. PracticeSuite is also at the forefront of concierge healthcare, providing doctors the technology required to practice subscription based, direct care primary medicine.
Michael Sculley Phone Number: 770-213-4723 Email: [email protected]


Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



